Subsequently, we validated these findings in PDX models and found that the tumors established from the clinical HCC tissues with high expression of CD133 and CD44 grew faster than those established from clinical HCC tissues with low expression of CD133 and CD44. Here, PROM1 is linked to hepatocellular carcinoma.